Depression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NIKBAKHSH NOVIN; MOUDI SUSSAN; Mohammadian Amiri Farimah; Niazifar Maede; BIJANI ALI

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES Year:2019 | Volume:29 | Issue:173 Page(s): 64-74

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

851

Download:

Cites:

Information Journal Paper

Title

Depression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study

Author(s)

Keywords

breast cancerQ2

depressionQ2

anxietyQ2

citalopramQ2

group-psychotherapyQ2

Abstract

Background and purpose: depression is a common psychiatric disorder in patients with breast cancer. This study was performed to follow-up breast cancer patients with depression receiving citalopram and group psychotherapy for six months. Materials and methods: This clinical trial was conducted in 40 breast cancer patients with depressive disorder. Among the patients, 20 received citalopram (20-40 mg/day) and the rest, besides the same dose of citalopram, attended 8 sessions of group psychotherapy. The patients were assessed at baseline and six months later. Hospital anxiety and depression Scale (HADS) and WHO-QOL BREF questionnaires were administered. Then treatment outcomes and quality of life were compared between the two groups applying t-test. Results: The mean scores for depression and anxiety were 12. 05± 2. 19 and 13. 25± 2. 90 at baseline which declined to 2. 05± 2. 06 and 4. 55± 2. 42, respectively, after six months (P<0. 05). Quality of life score in patients attending group psychotherapy sessions improved significantly after six months (80. 86) compared to that at baseline (40. 82), while slight changes were observed in the group receiving only citalopram (P<0. 001). Conclusion: citalopram and group psychotherapy were found to be significantly effective after six months on depression, anxiety, and quality of life in breast cancer patients with depressive disorder receiving citalopram.

Cites

No record.

References

Cite

APA: Copy

NIKBAKHSH, NOVIN, Mohammadian Amiri, Farimah, Niazifar, Maede, & BIJANI, ALI. (2019). Depression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 29(173 ), 64-74. SID. https://sid.ir/paper/44816/en

Vancouver: Copy

NIKBAKHSH NOVIN, Mohammadian Amiri Farimah, Niazifar Maede, BIJANI ALI. Depression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2019;29(173 ):64-74. Available from: https://sid.ir/paper/44816/en

IEEE: Copy

NOVIN NIKBAKHSH, Farimah Mohammadian Amiri, Maede Niazifar, and ALI BIJANI, “Depression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 29, no. 173 , pp. 64–74, 2019, [Online]. Available: https://sid.ir/paper/44816/en

Related Journal Papers